跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Ratiopharm Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 2, 2025
Approval ID
88b4d541bdb1ff14
Company
Ratiopharm Gmbh
Type
Standard
Approval Details
Approval Id
88b4d541bdb1ff14
Drug Cima Aemps Name
TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
957700000IP1
Holder Company Name
Ratiopharm Gmbh
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/ratiopharm-gmbh
Authorization Date
2025-06-02
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
3,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ratiopharm Gmbh
Company Detail Path
/organization/ratiopharm-gmbh
Company Information
Pharmaceutical Company Name
ratiopharm GmbH
Country Name
Germany
City Name
ulm,baden-württemberg,country_de
Address
Graf-Arco-Str. 3
Website
http://www.ratiopharm.de
Active Ingredients
DESFESOTERODINA SUCCINATO
3,50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 2, 2025
Approval ID
88b4d541bdb1ff14
Type
Standard
Back to CIMA-AEMPS Approvals
